Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors

Critical Reviews in Eukaryotic Gene Expression

Volumn 8, Issue 2, 1998, Pages 169-190

  Chen, J Don ^a   Li, Hui ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CBP p300; Coactivators corepressors; Histone acetylation deacetylation; RAC3 SRC 1 TIF2; SMRT N CoR

Indexed keywords

CELL NUCLEUS RECEPTOR; HORMONE RECEPTOR; STEROID HORMONE;

CELL DIFFERENTIATION; CELL MATURATION; CELL METABOLISM; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0032470461     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v8.i2.40     Document Type: Review

References (131)

1. Alland L, Muhle R, Hou H, Jr, Potes J, Chin L, Schreiber-Agus N, DePinho RA (1997): Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [see comments]. Nature 387:49-55.
2. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi O-P, Trent JM, Meltzer PS (1997): AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
3. Arany Z, Seller W, Livingston DM, Eckner R (1994): E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
4. Ayer DE, Lawrence QA, Eisenman RN (1995): Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
5. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, O'Malley BW (1995): The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15:76-86.
6. Baniahmad A, Thormeyer D, Renkawitz R (1997): τ4/τc/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both τ4 activation function and full dissociation of corepressors. Mol Cell Biol 17:4259-4271.
7. Beato M, Herrlich P, Schültz G (1995): Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
8. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D (1995): Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha [see comments]. Nature 375:377-382.
9. Brownell JE, Allis CD (1996): Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6:176-184.
10. Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au-Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, Samuels HH (1994): Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14:5756-5765.
11. Cavailles V, Dauvois S, P. S. Danielian PS, Parker MG (1994): Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013.
12. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG (1995): Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751.
13. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM (1996): Role of CBP/P300 in nuclear receptor signaling. Nature 383:99-103.
14. Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A (1995): Androgen receptor: an overview. Crit Rev Eukaryot Gene Exp 5:97-125.
15. Chatterjee VKK, Lee JK, Rentoumis A, Jameson JL (1989): Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci USA 86:9114-9118.
16. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM (1997): Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with p/CAF and CBP/p300. Cell 90:569-580.
17. Chen JD, Evans RM (1995): A transcriptional corepressor that interacts with nuclear hormone receptors [see comments]. Nature 377:454-457.
18. Chen JD, Umesono K, Evans RM (1996): SMRT isoforms mediate repression and antirepression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93:7567-7571.
19. Chiba H, Muramatsu M, Nomoto A, Kato H (1994): Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res 22:1815-1820.
20. Chien CT, Bartel PL, Sternglanz R, Fields S (1991): The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88:9578-9582.
21. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH (1993): Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
22. Cooney AJ, Leng X, Tsai SY, O'Malley BW, Tsai MJ (1993): Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. J Biol Chem 268:4152-4160.
23. Damm K, Evans RM (1993): Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha. Proc Natl Acad Sci USA 90:10668-10672.
24. Damm K, Heyman R, Umesono K, Evans RM (1993): Functional inhibition of retinoic acid response by dominant negative RAR mutants. Proc Natl Acad Sci USA 90:2989-2993.
25. DiRenzo J, Soderstrom M, Kurokawa R, Ogliastro MH, Ricote M, Ingrey S, Horlein A, Rosenfeld MG, Glass CK (1997): Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol 17:2166-2176.
26. Douarin BL, Zechel C, Garnier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R (1995): The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. The EMBO J 14:2020-2033.
27. Downes M, Burke LJ, Bailey PJ, Muscat GE (1996): Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res 24:4379-4386.
28. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ (1993): The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7:555-569.
29. Eggert M, Mows CC, Tripier D, Arnold R, Michel J, Nickel J, Schmidt S, Beato M, Renkawitz R (1995): A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J Biol Chem 270:30755-30759.
30. Fields S, Song O-k (1989): A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
31. Fondell JD, Brunel F, Hisatake K, Roeder RG (1996): Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression. Mol Cell Biol 16:281-287.
32. Fondell JD, Ge H, Roeder RG (1996): Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci USA 93:8329-8333.
33. Fondell JD, Roy AL, Roeder RG (1993): Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes Dev 7:1400-1410.
34. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812.
35. Forman BM, Umesono K, Chen J, Evans RM (1995): Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
36. Giguere V, Ong ES, Segui P, Evans RM (1987): Identification of a receptor for the morphogen retinoic acid. Nature 330:624-629.
37. Glass CK, Rose DW, Rosenfeld MG (1997): Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232.
38. Graf T, Beug H (1983): Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation. Cell 34:7-9.
39. Halachmi S, Marden E, Martin G, MacKay H, C. Abbondanza C, Brown M (1994): Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
40. Harding HP, Lazar MA (1993): The orphan receptor Rev-Erb repress transcription via a novel response element. Mol Cell Biol 15:4791-4802.
41. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993): The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
42. Hassig CA, Fleischer TC, Billin AN, S. L. Schreiber SL, Ayer DE (1997): Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347.
43. Heery DM, Kalkhoven E, Hoare S, Parker MG (1997): A signature motif in transcriptional coactivators mediates binding to nuclear receptors. Nature 387:733-736.
44. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG (1997): A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression [see comments]. Nature 387:43-48.
45. Henttu PM, Kalkhoven E, Parker MG (1997): AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 17:1832-1839.
46. Hollenberg AN, Monden T, Wondisford FE (1995): Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini. J Biol Chem 270:14274-14280.
47. Hong H, Kohli K, Garabedian MJ, Stallcup MR (1997): GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744.
48. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR (1996): GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952.
49. Horlein AJ, Heinzel T, Rosenfeld MG (1996): Gene regulation by thyroid hormone receptors. Endocrinol Diabetes 3:412-416.
50. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG (1995): Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor [see comments]. Nature 377:397-404.
51. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L (1996): Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177.
52. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB (1997): The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 11:693-705.
53. Jeyakumar M, Tanen MR, Bagchi MK (1997): Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transcription by thyroid hormone receptor. Mol Endocrinol 11:755-767.
54. Johnson AD (1995): The price of repression. Cell 81:655-658.
55. Kadosh D, Struhl K (1997): Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell 89:365-371.
56. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996): A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
57. Kastner P, Mark M, Chambon P (1995): Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
58. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR (1993): BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366:170-174.
59. 2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Cell 83:813-819.
60. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM (1992): Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature 355:446-449.
61. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995): Polarity-specific activities of retinoic acid receptors determined by a corepressor [see comments]. Nature 377:451-454.
62. Kwok RPS, Lundblad JR, Chrivia JC, Richards JP, Bächinger HP, Brennan RG, Roberts SGE, Green MR, Goodman RH (1994): Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226.
63. Laherty CD, Yang W-M, Sun J-M, Davie JR, Seto E, Eisenman RN (1997): Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89:349-356.
64. Lala DS, Mukherjee R, Schulman IG, Koch SS, Dardashti LJ, Nadzan AM, Croston GE, Evans RM, Heyman RA (1996): Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383:450-453.
65. Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, Losson R, Chambon P (1996): A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J 15:6701-6715.
66. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R (1995): The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033.
67. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD (1995): Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
68. Li H, Gomes PJ, Chen JD (1997): RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC1 and TIF2. Proc Natl Acad Sci USA 94:8479-8484.
69. Li H, Leo C, Chen JD (1997): Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol Endocrinol 11:2025-2037.
70. Li H, Chen JD (1998): The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation. J Biol Chem 273:5948-5954.
71. Lindebro MC, Poellinger L, Whitelaw ML (1995): Protein-protein interaction via PAS domains: role of the PAS domain in positive and negative regulation of the bHLH/PAS dioxin receptor-Arnt transcription factor complex. EMBO J 14:3528-3539.
72. Mangelsdorf DJ, Evans RM (1995): The RXR heterodimers and orphan receptors. Cell 83:841-850.
73. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995): The nuclear receptor superfamily: the second decade. Cell 83:835-839.
74. McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS (1996): Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA 93:10069-10073.
75. Meyer M, Gronemeyer H, Turcotte B, Bocquel M, Tasset D, Chambon P (1989): Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442.
76. Muchardt C, Yaniv M (1993): A human homologue of Sacharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 12:4279-4290.
77. Mukherjee R, Davies PJA, Crombie DL, Bischoff ED, Cesario RMM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR Jr, Heyman RA (1997): Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists (Letter to Nature). Nature 386:407-410.
78. Murre C, McCaw PS, Baltimore D (1989): A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
79. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, Weintraub H, Baltimore D (1989): Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
80. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM (1997): Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
81. Netzer WJ, Hartl FU (1997): Recombination of protein domains facilitated by co-translational folding in eukaryotes. Nature 388:343-349.
82. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW (1995): Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
83. Oppenheimer JH, Schwartz HL, Mariash CN, Kinlaw WB, Wong NC, Freake HC (1987): Advances in our understanding of thyroid hormone action at the cellular level. Endocrinol Rev 8:288-308.
84. Parker MG, White R (1996): Nuclear receptors spring into action. Nature Struct Biol 3:113-115.
85. Pazin MJ, Kadonaga JT (1997): What's up and down with histone deacetylation and transcription? Cell 89:325-328.
86. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D (1995): Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
87. Renkawitz R (1993): Repression mechanisms of v-ERBA and other members of the steroid receptor superfamily. Ann NY Acad Sci 684:1-10.
88. Sande S, Privalsky ML (1996): Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825.
89. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, A. I. Skoultchi AI, DePinho RA (1995): An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell. 80:777-786.
90. Schroen DJ, Chen JD, Vincenti MP, Brinckerhoff CE (1997): The nuclear receptor corepressor SMRT inhibits collagenase (MMP-1) transcription through an HRE-independent mechanism. BBRC 237:52-58.
91. Schüle R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW Evans RM (1990): Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61:497-504.
92. Seol W, Choi HS, Moore DD (1995): Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 9:72-85.
93. Seol W, Mahon MJ, Lee YK, Moore DD (1996): Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol Endocrinol 10:1646-1655.
94. Shibata H, Nawaz Z, Tsai SY, O'Malley BW. Tsai M-J (1997): Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol Endocrinol 11:714-724.
95. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai M-J, O'Malley BW (1997): Recent Prog Horm Res 52:1-37.
96. Smith CL, Nawas Z, O'Malley BW (1997): Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657-666.
97. Smith CL, Onate SA, Tsai MJ O'Malley BW (1996): CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA 93:8884-8888.
98. Soderstrom M, Vo A, Heinzel T, Lavinsky RM, Yang WM, Seto E, Peterson DA, M. G. Rosenfeld MG, Glass CK (1997): Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol Endocrinol 11:682-692.
99. Swanson HI, Chan WK, Bradfield CA (1995): DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J Biol Chem 270: 26292-26302.
100. Tagami T, Madison LD, Nagaya T, Jameson JL (1997): Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol 17:2642-2648.
101. Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW (1996): Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137:3594-3597.
102. Taunton J, Hassig CA, Schreiber SL (1996): A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p [see comments]. Science 272:408-411.
103. Thummel CS (1995): From embryogenesis to metamorphosis: the regulation and function of Drosophila nuclear receptor superfamily members. Cell 83:871-877.
104. Tjian R, Maniatis T (1994): Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5-8.
105. Tong GX, Jeyakumar M, Tanen MR, Bagchi MK (1996): Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol Cell Biol. 16:1909-1920.
106. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG (1997): The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684.
107. Tsai S, Collins SJ (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90: 7153-7157.
108. Umesono K, Murakami KK, Thompson CC, Evans RM (1991): Direct repeats as selective response elements for the thyroid hormone induced gene expression through a common responsive element. Cell 65:1255-1266.
109. Vidal M, Gaber RF (1991): RPD3 encodes a second factor required to achieve maximun positive and negative transcriptional states in Saccharomyces cerevisiae. Mol Cell Biol 11:6317-6327.
110. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H (1996): TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15: 3667-3675.
111. Wade PA, Pruss D, Wolffe AP (1997): Histone acetylation: chromatin in action. Trends Biochem Sci 22:128-132.
112. Wagner RL, Apriletti JW, West BL, Baxter JD, Fletterick RJ (1995): A structural role for hormone in the thyroid hormone receptor ligand-binding domain. Nature 378:690-697.
113. Walfish PG, Yoganathan T, Yang YF, Hong H, Butt TR, Stallcup MR (1997) Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc Natl Acad Sci USA 94:3697-3702.
114. Wang L, Mizzen C, Ying C, Candau R, Barlev N, Brownell J, Allis CD, Berger SL (1997): Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation. Mol Cell Biol 17:519-527.
115. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ (1995): LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033-1045.
116. Wolffe AP (1996): Histone deacetylase: a regulator of transcription. Science 272:408-411.
117. Wolffe AP (1997): Sinful repression. Nature 387:16-17.
118. Wolffe AP, Pruss D (1996): Targeting chromatin disruption: transcription regulators that acetylates histones. Cell 86:817-819.
119. Wong J, Shi Y-B, Wolffe AP (1997): Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J 16:3158-3171.
120. Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW (1996): The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc Natl Acad Sci USA 93:12195-12199.
121. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E (1996): Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 93:12845-12850.
122. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y (1996): A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324.
123. Yao TP, Ku G, Zhou N, Scully R, Livingston DM (1996): The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 93:10626-10631.
124. Yeh S, Chang C (1996): Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93:5517-5521.
125. Yen PM, Liu Y, Sugawara A, Chin WW (1996): Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity. J Biol Chem 271:10910-10916.
126. Yoh SM, Chatterjee VKK, Privalsky ML (1997): Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11:470-480.
127. Yu VC, Delsert C, Anderson B, Holloway JM, Devary OV, Narr AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG (1991): RXRb: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266.
128. Zamir I, Harding HP, Atkins GB, Horlein A, Glass CK, Rosenfeld MG, Lazar MA (1996): A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458-5465.
129. Zamir I, Zhang J, Lazar MA (1997): Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev 11:835-846.
130. Zelzer E, Wappner P, Shilo B-Z (1997): The PAS domain confers target gene specificity of Drosophila bHLH/PAS proteins. Genes Dev 11:2065-2079.
131. Zhu Y, Qi C, Calandra C, Rao MS, Reddy JK (1996): Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. Gene Exp 6:185-195.